ROBERTO, GIUSEPPE

ROBERTO, GIUSEPPE  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.013 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; Poluzzi, E. 2015-01-01 CEPHALALGIA - 1.01 Articolo in rivista -
Factors Influencing the Disproportional Association Between Triptans and Cerebrovascular Events Within the FDA_AERS Database: Causal Association or Reporting Bias? G. Roberto; C. Piccinni; E. Poluzzi 2013-01-01 - Adis 4.03 Poster -
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy Biagi C.; Poluzzi E.; Roberto G.; Puccini A.; Vaccheri A.; D'Alessandro R.; Motola D.; Montanaro N. 2011-01-01 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Pattern of Triptan Use in a Sample of the Italian General Population C. Biagi; E. Poluzzi; D. Motola; G. Roberto; A. Puccini; A. Vaccheri; R. D’Alessandro; N. Montanaro. 2010-01-01 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY - 4.02 Riassunto (Abstract) -
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature G. Roberto; C. Biagi; N. Montanaro; A. Koci; U. Moretti; D. Motola 2012-01-01 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Ticlopidine’s safety profile: a case/non case study on the basis of the spontaneous ADR reporting in Italy. Motola D.; Roberto G.; Biagi C.; Vargiu A.; Donati M.; Costantini D.; Montanaro N. 2009-01-01 BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY - 4.02 Riassunto (Abstract) -
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database Roberto, Giuseppe; Piccinni, Carlo; D'Alessandro, Roberto; Poluzzi, Elisabetta 2014-01-01 CEPHALALGIA - 1.01 Articolo in rivista -
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database Roberto G; Piccinni C; Biagi C; Koci A; Motola D; Vaccheri A; Montanaro N; Poluzzi E. 2012-01-01 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Wiley Blackewell 4.02 Riassunto (Abstract) -
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). Biagi C.; Montanaro N.; Buccellato E.; Roberto G.; Vaccheri A.; Motola D. 2013-01-01 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -